Independent · Reader-Supported · Editorially Reviewed
§ Brand Review · GLP-1 Weight Loss

Direct Meds Review

Compounded GLP-1 clinic with transparent pricing and dedicated nurse support.

Last reviewed August 2026
4 studies cited
Fact-checked 26 August 2026Last updated 26 August 2026From $249 – $297/moEditor Score 4.3 / 5Trustpilot 4.6 · Excellent

Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology

Quick Verdict

Compounded GLP-1 clinic with transparent pricing and dedicated nurse support.

Who it's for: Direct Meds fits buyers who want a published all-in compounded GLP-1 structure and value having a stated nurse-support layer rather than only an automated intake. The online intake and clinician review workflow may suit people who prioritize remote access over an in-person clinic visit.

Bottom line: Direct Meds is easier to compare than a program that separates its membership fee from medication, provided the public $249 and $297 starting points match the treatment path you are offered. Skip it if you specifically want brand-name GLP-1 access or in-state pickup.

Pros
  • Transparent published pricing
  • Nurse support included in plan
  • Fast shipping on compounded plans
Cons
  • Compounded only, no brand-name GLP-1
  • Insurance not accepted
  • Newer brand, fewer third-party reviews

Pros & Cons In Detail

Transparent published pricing
Clear, line-itemed pricing is increasingly rare in telehealth, and Direct Meds discloses what you'll pay before you start a consult, not after card capture.
Nurse support included in plan
In practice this is one of the differentiators that pushes Direct Meds's editor score above the category median.
Fast shipping on compounded plans
Reliable shipping is the most underrated quality signal in telehealth. patients who switch providers usually do so because of refill timing, not price.
Compounded only, no brand-name GLP-1
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.
Insurance not accepted
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.
Newer brand, fewer third-party reviews
It's a real trade-off worth knowing about before you commit, even if it isn't a deal-breaker on its own.

Direct Meds Pricing

Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at Direct Meds.

Program / Membership FeeIncluded in observed all-in plan price
Medication Cost (From)From $249 – $297/mo
What This Means For You

At the August 26, 2026 price check, Direct Meds listed sublingual semaglutide from $249/month and injections from $297/month. Its public process page says medication, nurse support, shipping, and digital follow-ups are included. A licensed clinician reviews the online intake; confirm treatment, dose, and checkout terms before purchase.

Who Direct Meds Is For

Direct Meds fits buyers who want a published all-in compounded GLP-1 structure and value having a stated nurse-support layer rather than only an automated intake. The online intake and clinician review workflow may suit people who prioritize remote access over an in-person clinic visit.

How Direct Meds Markets Itself

Adults who want a transparent compounded GLP-1 program with a dedicated nurse contact instead of just an automated app.

Signature Programs

  • ›Compounded GLP-1 weight loss
  • ›Hair-loss program with finasteride and minoxidil
  • ›Anti-aging protocols with sermorelin

Medication Formulary

Full Formulary
compounded semaglutidecompounded tirzepatideminoxidilfinasteride

The Bottom Line

Direct Meds is easier to compare than a program that separates its membership fee from medication, provided the public $249 and $297 starting points match the treatment path you are offered. Skip it if you specifically want brand-name GLP-1 access or in-state pickup.

With an editor score of 4.3 / 5 across cost, experience, and trust, Direct Meds is one of the strong mid-tier options in the glp-1 weight loss category we cover.

See how Direct Meds compares in our full glp-1 weight loss rankings, or read the Best Telehealth GLP-1 Providers guide. Our methodology explains how we score each provider.

§ FAQ

Frequently Asked Questions

References
  1. Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
  2. FDA Federal Register 2024 (Semaglutide shortage end) · FDA removed semaglutide from the drug shortage list in October 2024, ending the legal basis for compounding.
  3. Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss vs 3.1% placebo at 72 weeks in SURMOUNT-1.
  4. FDA Federal Register 2024 (Tirzepatide shortage end) · FDA removed tirzepatide from the drug shortage list in October 2024.

RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.

§ Readers Also Compared

How Direct Meds Stacks Up

Alternatives To Direct Meds

§ Continue Reading